Annual Shareholders Equity
-$7.85 M
-$14.82 M-212.73%
30 June 2024
Summary:
Renalytix annual stockholders equity is currently -$7.85 million, with the most recent change of -$14.82 million (-212.73%) on 30 June 2024. During the last 3 years, it has fallen by -$102.96 million (-108.26%). RNLX annual shareholders equity is now -108.26% below its all-time high of $95.10 million, reached on 30 June 2021.RNLX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$11.32 M
-$3.46 M-44.12%
30 September 2024
Summary:
Renalytix quarterly stockholders equity is currently -$11.32 million, with the most recent change of -$3.46 million (-44.12%) on 30 September 2024. Over the past year, it has dropped by -$9.83 million (-659.15%). RNLX quarterly shareholders equity is now -111.90% below its all-time high of $95.10 million, reached on 30 June 2021.RNLX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNLX Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -212.7% | -659.1% |
3 y3 years | -108.3% | -118.9% |
5 y5 years | -191.8% | - |
RNLX Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -108.3% | at low | -118.9% | at low |
5 y | 5 years | -108.3% | at low | -111.9% | at low |
alltime | all time | -108.3% | at low | -111.9% | at low |
Renalytix Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$11.32 M(+44.1%) |
June 2024 | -$7.85 M(-212.7%) | -$7.85 M(-29.3%) |
Mar 2024 | - | -$11.11 M(-516.6%) |
Dec 2023 | - | $2.67 M(-278.9%) |
Sept 2023 | - | -$1.49 M(-121.4%) |
June 2023 | $6.97 M(-77.2%) | $6.97 M(-61.5%) |
Mar 2023 | - | $18.10 M(+103.7%) |
Dec 2022 | - | $8.88 M(-52.8%) |
Sept 2022 | - | $18.84 M(-38.4%) |
June 2022 | $30.61 M | $30.61 M(+4.1%) |
Mar 2022 | - | $29.41 M(-35.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | - | $45.80 M(-23.6%) |
Sept 2021 | - | $59.97 M(-36.9%) |
June 2021 | $95.10 M(+497.7%) | $95.10 M(+18.8%) |
Mar 2021 | - | $80.03 M(-7.9%) |
Dec 2020 | - | $86.90 M(-2.6%) |
Sept 2020 | - | $89.19 M(+460.5%) |
June 2020 | $15.91 M(+86.1%) | $15.91 M(-61.4%) |
Dec 2019 | - | $41.18 M(+381.5%) |
June 2019 | $8.55 M(-1803.4%) | $8.55 M(-72.0%) |
Dec 2018 | - | $30.53 M |
June 2018 | -$502.00 K | - |
FAQ
- What is Renalytix annual stockholders equity?
- What is the all time high annual shareholders equity for Renalytix?
- What is Renalytix annual shareholders equity year-on-year change?
- What is Renalytix quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Renalytix?
- What is Renalytix quarterly shareholders equity year-on-year change?
What is Renalytix annual stockholders equity?
The current annual shareholders equity of RNLX is -$7.85 M
What is the all time high annual shareholders equity for Renalytix?
Renalytix all-time high annual stockholders equity is $95.10 M
What is Renalytix annual shareholders equity year-on-year change?
Over the past year, RNLX annual stockholders equity has changed by -$14.82 M (-212.73%)
What is Renalytix quarterly stockholders equity?
The current quarterly shareholders equity of RNLX is -$11.32 M
What is the all time high quarterly shareholders equity for Renalytix?
Renalytix all-time high quarterly stockholders equity is $95.10 M
What is Renalytix quarterly shareholders equity year-on-year change?
Over the past year, RNLX quarterly stockholders equity has changed by -$9.83 M (-659.15%)